
4 Midcap HDFC Mutual Fund Stocks to Watch for Future Multibagger Potential: Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis
Godrej Consumer Rs 822. Federal Bank Rs 346. Fortis Healthcare Rs 759.50. Mphasis Rs 2,518. Market caps from Rs 47,225 crore to Rs 83,656 crore. Data as of 28 Oct 2026.
Updated: 29 Oct 2026 • 11:32 am
Posted by:

Quick Answer
Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis are the 4 picks in this HDFC mutual fund stocks watchlist, with market caps between Rs 47,225 crore and Rs 83,656 crore. Godrej Consumer stands out for the largest market cap at Rs 83,656 crore, while Federal Bank offers the fastest profit growth, 22.90% a year since FY22. PE ratios run from 15.39 to 54.01, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.
HDFC mutual fund stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis meet that test, with market caps from Rs 47,225 crore to Rs 83,656 crore and Godrej Consumer offering the largest market cap at Rs 83,656 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and HDFC Mutual Fund or one of its schemes listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and HDFC Mutual Fund or one of its schemes listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening HDFC mutual fund stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are HDFC Mutual Fund Stocks and Why Do They Attract Multibagger Interest?
HDFC mutual fund stocks are shares of mid sized companies in which HDFC Mutual Fund or one of its schemes is named among the top domestic institutional holders in the latest shareholding pattern. The four here cover household products, private banking, IT services and hospitals.
When a leading fund house like HDFC Mutual Fund holds a large stake, it shows that its research teams have studied the business closely and backed it with investors money. For HDFC mutual fund stocks, both FY26 and the latest quarter showed growth. Investors researching HDFC mutual fund stocks get a fuller picture by reading growth and valuation together. The table below lines up HDFC mutual fund stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use HDFC mutual fund stocks as a starting point for your own research.
HDFC Mutual Fund Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 28 October 2026. Federal Bank has the lowest PE of the group at 15.39, while Mphasis posts the highest return on equity at 17.34%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Godrej Consumer Products | 822 | 83,656 | 43.72 | 34.40 | 14.71% | 6.61 | 822.00 to 1,273.90 |
| Federal Bank | 346 | 82,902 | 15.39 | 11.94 | 12.60% | 2.01 | 211.52 to 371.70 |
| Fortis Healthcare | 759.50 | 57,814 | 54.01 | 60.75 | 10.53% | 5.85 | 565.00 to 759.50 |
| Mphasis | 2,518 | 47,225 | 24.72 | 18.49 | 17.34% | 4.39 | 2,013.00 to 2,975.00 |
Godrej Consumer: Profit Compounding at 1.08% a Year
Godrej Consumer Products sells household insecticides, soaps, hair colour and personal care brands in India, Africa and Asia. It reported FY26 revenue of Rs 15,444.07 crore, up 7.90% year on year, and net profit of Rs 1,861.47 crore, up 0.50%. Revenue has compounded at 5.71% a year since FY22. Operating margin was 19.45% in FY26. The debt-to-equity ratio is 0.35.
In the June 2026 quarter, revenue rose 14.17% to Rs 4,277.35 crore and net profit grew 11.51% to Rs 504.52 crore. Domestic institutions raised their holding from 12.40% in June 2025 to 19.59% in June 2026. The stock trades at a PE of 43.72 against an industry PE of 34.40, with a return on equity of 14.71%. The dividend yield is 2.45%.
Federal Bank: 22.90% Profit CAGR Since FY22
Federal Bank is a Kerala-based private sector bank with a strong NRI deposit base and a growing retail, small business and digital franchise. It reported FY26 total income of Rs 34,272.42 crore, up 7.00% year on year, and net profit of Rs 4,483.38 crore, up 6.71%. Net profit has compounded at 22.90% a year since FY22, while total income has grown 20.05% a year.
The stock trades at a PE of 15.39 against an industry PE of 11.94, with a return on equity of 12.60%. In the September 2026 quarter, total income rose 19.01% to Rs 9,903.41 crore and net profit grew 53.42% to Rs 1,564.06 crore. The share price has gained 259.57% over five years and 57.58% over the past year. Domestic institutions raised their holding from 48.17% in June 2025 to 49.28% in June 2026.
Fortis Healthcare: Five-Year Gain of 241.47%
Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.
In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 241.47% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026. The stock trades at a PE of 54.01 against an industry PE of 60.75, below the sector average.
Mphasis: Profit Compounding at 6.81% a Year
Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.
The stock trades at a PE of 24.72 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.50%. In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026.
HDFC Mutual Fund Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these HDFC mutual fund stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Godrej Consumer | 15,444.07 | 1,861.47 | 7.90% | 5.71% | 1.08% |
| Federal Bank | 34,272.42 | 4,483.38 | 7.00% | 20.05% | 22.90% |
| Fortis Healthcare | 9,178.50 | 1,064.19 | 16.93% | 12.43% | 7.73% |
| Mphasis | 16,205.54 | 1,862.60 | 11.88% | 7.53% | 6.81% |
Check the Univest Screener for live data on these HDFC mutual fund stocks
Institutional Holding in Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis
Institutional holding shows who is backing these HDFC mutual fund stocks alongside the promoter. The table uses the latest reported quarter for each. Federal Bank has the deepest institutional backing, with FII and DII together holding 76.99% as of June 2026. Domestic institutions increased their holding over the past year in Godrej Consumer (from 12.40% to 19.59%), Federal Bank (from 48.17% to 49.28%), Fortis Healthcare (from 29.79% to 32.23%) and Mphasis (from 37.07% to 45.85%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Godrej Consumer | 53.05% | 12.33% | 19.59% | 15.03% | June 2026 |
| Federal Bank | Nil | 27.71% | 49.28% | 23.01% | June 2026 |
| Fortis Healthcare | 31.17% | 25.20% | 32.23% | 11.40% | June 2026 |
| Mphasis | 30.53% | 19.39% | 45.85% | 4.23% | September 2026 |
Risks to Weigh in HDFC Mutual Fund Stocks
Being careful with HDFC mutual fund stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Mphasis trades at a PE of 24.72 against an industry PE of 18.49, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between HDFC Mutual Fund Stocks
Picking from HDFC mutual fund stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (11.94 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis live prices.
Conclusion
Among HDFC mutual fund stocks, Godrej Consumer stands out for the largest market cap at Rs 83,656 crore, Federal Bank for the fastest profit growth, 22.90% a year since FY22, Fortis Healthcare for 16.93% revenue growth in FY26 and Mphasis for the highest return on equity at 17.34%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing HDFC mutual fund stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on HDFC Mutual Fund Stocks to Watch
Which are the best HDFC mutual fund stocks to watch for multibagger potential?
Ans. Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis are the 4 names this list highlights, with market caps of Rs 83,656 crore, Rs 82,902 crore, Rs 57,814 crore and Rs 47,225 crore respectively. Godrej Consumer is notable for the largest market cap at Rs 83,656 crore. Federal Bank stands out for the fastest profit growth, 22.90% a year since FY22. Fortis Healthcare offers 16.93% revenue growth in FY26. Mphasis brings the highest return on equity at 17.34%. These are watchlist names for HDFC mutual fund stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Mphasis a good stock for long-term investors?
Ans. Mphasis has a return on equity of 17.34%, a PE of 24.72 against an industry PE of 18.49 and a market cap of Rs 47,225 crore. Net profit has compounded at 6.81% a year since FY22, and FY26 revenue rose 11.88% while June 2026 quarter net profit grew 10.82%. Long-term returns in HDFC mutual fund stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Federal Bank become a multibagger from here?
Ans. Federal Bank has already gained 259.57% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in HDFC mutual fund stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 22.90% a year since FY22, and FY26 revenue rose 7.00%. At a PE of 15.39 against an industry PE of 11.94, valuation should be checked against that growth before investing.
What is the market cap of Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis?
Ans. As of 28 October 2026, Godrej Consumer has a market cap of Rs 83,656 crore, Federal Bank has a market cap of Rs 82,902 crore, Fortis Healthcare has a market cap of Rs 57,814 crore and Mphasis has a market cap of Rs 47,225 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on HDFC mutual fund stocks.
What are the risks of investing in HDFC mutual fund stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 24.72 against an industry PE of 18.49, so earnings growth needs to hold up.
Why is Mphasis trading at a PE of 24.72?
Ans. Mphasis' PE of 24.72 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in HDFC mutual fund stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Godrej Consumer, Federal Bank, Fortis Healthcare and Mphasis?
Ans. As of the latest reported quarter, FII and DII together hold 31.92% of Godrej Consumer (12.33% and 19.59%), 76.99% of Federal Bank (27.71% and 49.28%), 57.43% of Fortis Healthcare (25.20% and 32.23%) and 65.24% of Mphasis (19.39% and 45.85%). Rising institutional holding is a useful signal in HDFC mutual fund stocks, though it should be read with earnings trends rather than on its own.
Recent Articles

3 Large Jewellery Retailer, Premium Footwear Retailer and Mid Priced Hotel Chain Stocks With a Strong Future Roadmap: Kalyan Jewellers India, Metro Brands and Lemon Tree Hotels
29 October 2026

3 Largest Footwear Retailer, Largest Hospitality Company and Jewellery Manufacturer Stocks With a Strong Future Roadmap: Bata India, Indian Hotels Company and Sky Gold and Diamonds
29 October 2026

3 Electronics Manufacturing Services Company, Consumer Electricals Maker and Wires and Cables Producer Stocks With a Strong Future Roadmap: Syrma SGS Technology, V-Guard Industries and RR Kabel
29 October 2026

3 Cryogenic Tanks and Systems Leader, Fans and Switchgear Major and Industrial Gears Maker Stocks With a Strong Future Roadmap: Inox India, Havells India and Elecon Engineering
29 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Large Jewellery Retailer, Premium Footwear Retailer and Mid Priced Hotel Chain Stocks With a Strong Future Roadmap: Kalyan Jewellers India, Metro Brands and Lemon Tree Hotels
3 Largest Footwear Retailer, Largest Hospitality Company and Jewellery Manufacturer Stocks With a Strong Future Roadmap: Bata India, Indian Hotels Company and Sky Gold and Diamonds
3 Electronics Manufacturing Services Company, Consumer Electricals Maker and Wires and Cables Producer Stocks With a Strong Future Roadmap: Syrma SGS Technology, V-Guard Industries and RR Kabel
3 Cryogenic Tanks and Systems Leader, Fans and Switchgear Major and Industrial Gears Maker Stocks With a Strong Future Roadmap: Inox India, Havells India and Elecon Engineering
3 Commodity Derivatives Exchange, Wealth and Asset Services Group and Mutual Fund Distributor Stocks With a Strong Future Roadmap: Multi Commodity Exchange of India, Nuvama Wealth Management and Prudent Corporate Advisory Services

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





